HCID 71185992, compound → HCID 71203184, compound
Reaction equation
Cl[C:2]1[CH:34]=[CH:33][C:5]([CH2:6][C:7]2[N:8]=[C:9]([CH2:29][CH:30]([CH3:32])[CH3:31])[C:10]3[N:15]=[C:14]([C:16]4[CH:26]=[C:25]([CH3:27])[C:19]([O:20][CH2:21][C:22]([OH:24])=[O:23])=[C:18]([CH3:28])[CH:17]=4)[O:13][C:11]=3[N:12]=2)=[CH:4][CH:3]=1>[Pd]>[CH2:6]([C:7]1[N:8]=[C:9]([CH2:29][CH:30]([CH3:32])[CH3:31])[C:10]2[N:15]=[C:14]([C:16]3[CH:26]=[C:25]([CH3:27])[C:19]([O:20][CH2:21][C:22]([OH:24])=[O:23])=[C:18]([CH3:28])[CH:17]=3)[O:13][C:11]=2[N:12]=1)[C:5]1[CH:4]=[CH:3][CH:2]=[CH:34][CH:33]=1Participants
3
Reactant 1
Product 1
Reagents, catalysts & solvents 1
Procedure
10 mg of palladium on carbon (10%) were added to a solution of 50 mg of {4-[5-(4-chlorobenzyl)-7-isobutyloxazolo[5,4-d]pyrimidin-2-yl]-2,6-dimethylphenoxy}acetic acid, and the mixture was hydrogenated at 5 bar overnight. Three times, another 10 mg of palladium on carbon (10%) were added and the mixture was in each case hydrogenated for a day. For work-up, the catalyst was filtered off through Celite and the solution obtained was concentrated. The residue was purified by HPLC. This gave 7 mg (18%) of the title compound.
Workup
- customwas hydrogenated at 5 bar overnight
- waithydrogenated for a day
- filtrationFor work-up, the catalyst was filtered off through Celite
- customthe solution obtained
- concentrationwas concentrated
- customThe residue was purified by HPLC
Sources & evidence
- ORD record
- ord-4009d958185743968d2c79f5e0884749
- Source dataset
- uspto-grants-2016_04
- Patent number
- US09321787B2
Reaction notes
Loading…